Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.24
Price to sales ratio
6.76

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3575
ARTV
Artiva Biotherapeutics, Inc. - Common Stock
8.93 USD-7.37%-5.40%+4.20%+114.66%220.72 M USD
3577
KROS
Keros Therapeutics, Inc. - common stock
11.10 USD-5.93%+0.36%+7.25%-26.49%219.69 M USD
3583
AVXL
Anavex Life Sciences Corp. - Common Stock
2.35 USD-6.00%-12.64%-7.84%-79.39%217.78 M USD
3584
CGEN
Compugen Ltd. - Ordinary Shares
2.30 USD-3.77%-1.71%+13.30%+42.86%217.47 M USD

Frequently asked questions about Bicycle Therapeutics plc - American Depositary Shares

What is the Bicycle Therapeutics plc - American Depositary Shares stock price today?

The current price of Bicycle Therapeutics plc - American Depositary Shares (BCYC) is 4.35. Over the past 24 hours, the stock has changed by -1.36%. Follow the BCYC chart for real-time price dynamics.

What is the stock ticker of Bicycle Therapeutics plc - American Depositary Shares?

Bicycle Therapeutics plc - American Depositary Shares trades under the ticker BCYC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bicycle Therapeutics plc - American Depositary Shares stock going up?

BCYC has changed by 0.00% over the last week, +2.84% over the last month, and -46.49% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Bicycle Therapeutics plc - American Depositary Shares net income for the last quarter?

Bicycle Therapeutics plc - American Depositary Shares reported net income of -60.83 M for the last quarter. The previous quarter showed -20.15 M, which means net income changed by -201.80%.

How many employees does Bicycle Therapeutics plc - American Depositary Shares have?

As of the latest available data, Bicycle Therapeutics plc - American Depositary Shares has 288 employees. Workforce size can provide additional context about the company's scale and operations.

What is Bicycle Therapeutics plc - American Depositary Shares EBITDA?

Bicycle Therapeutics plc - American Depositary Shares EBITDA is -64.35 M, and its EBITDA margin is -7 255.13%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Bicycle Therapeutics plc - American Depositary Shares stock?

You can buy Bicycle Therapeutics plc - American Depositary Shares (BCYC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bicycle Therapeutics plc - American Depositary Shares stock?

Investing in Bicycle Therapeutics plc - American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BCYC chart and related analysis on metatrader.com as part of your research.

News